|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS |
aUpres-Ea3852;
bInserm-Ea3855, Ifr135, Université François Rabelais de Tours and Chru de Tours, Tours, France
Key Words. Stem cells • Mobilization • Blood • Hypoxia • Hematopoiesis
Correspondence: Jorge Domenech, M.D., Ph.D., Laboratoire d'Hématopoïèse, Inserm-ESPRI-EA3855, Faculté de Médecine, 10 Boulevard Tonnellé, 37 032 Tours Cedex, France. Telephone: 33-247-47-47-21; Fax: 33-247-47-69-34; e-mail: domenech{at}med.univ-tours.fr
Received March 21, 2006;
accepted for publication May 6, 2006.
First published online in STEM CELLS EXPRESS June 15, 2006.
MSCs constitute a population of multipotential cells giving rise to adipocytes, osteoblasts, chondrocytes, and vascular-smooth muscle-like hematopoietic supportive stromal cells. It remains unclear whether MSCs can be isolated from adult peripheral blood under stationary conditions and whether they can be mobilized in a way similar to hematopoietic stem cells. In this report, we show that MSCs are regularly observed in the circulating blood of rats and that the circulating MSC pool is consistently and dramatically increased (by almost 15-fold) when animals are exposed to chronic hypoxia. The immunophenotype and the adipocytic, osteoblastic, and chondrocytic differentiation potential of circulating MSCs were similar to those of bone marrow MSCs. Hypoxia-induced mobilization appears to be specific for MSCs since total circulating hematopoietic progenitor cells were not significantly increased. Our data provide an in vivo model amenable to analysis of MSC-mobilizing factors.
This article has been cited by other articles:
![]() |
L. da Silva Meirelles, A. I. Caplan, and N. B. Nardi In Search of the In Vivo Identity of Mesenchymal Stem Cells Stem Cells, September 1, 2008; 26(9): 2287 - 2299. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Psaltis, A. C.W. Zannettino, S. G. Worthley, and S. Gronthos Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair Stem Cells, September 1, 2008; 26(9): 2201 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kucia, M. Wysoczynski, W. Wu, E. K. Zuba-Surma, J. Ratajczak, and M. Z. Ratajczak Evidence That Very Small Embryonic-Like Stem Cells Are Mobilized into Peripheral Blood Stem Cells, August 1, 2008; 26(8): 2083 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rosova, M. Dao, B. Capoccia, D. Link, and J. A. Nolta Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells Stem Cells, August 1, 2008; 26(8): 2173 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Y Rochefort Circulating progenitor cells in coronary heart disease Heart, June 1, 2008; 94(6): 793 - 794. [Full Text] [PDF] |
||||
![]() |
A. Koc, N. Emin, A. E. Elcin, and Y. M. Elcin In Vitro Osteogenic Differentiation of Rat Mesenchymal Stem Cells in a Microgravity Bioreactor Journal of Bioactive and Compatible Polymers, May 1, 2008; 23(3): 244 - 261. [Abstract] [PDF] |
||||
![]() |
M. Sasaki, R. Abe, Y. Fujita, S. Ando, D. Inokuma, and H. Shimizu Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type J. Immunol., February 15, 2008; 180(4): 2581 - 2587. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Wojakowski, M Kucia, M Kazmierski, M Z Ratajczak, and M Tendera Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart, January 1, 2008; 94(1): 27 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Otsuru, K. Tamai, T. Yamazaki, H. Yoshikawa, and Y. Kaneda Circulating Bone Marrow-Derived Osteoblast Progenitor Cells Are Recruited to the Bone-Forming Site by the CXCR4/Stromal Cell-Derived Factor-1 Pathway Stem Cells, January 1, 2008; 26(1): 223 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chamberlain, J. Fox, B. Ashton, and J. Middleton Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing Stem Cells, November 1, 2007; 25(11): 2739 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rubinek, V. Chesnokova, I. Wolf, K. Wawrowsky, G. Vlotides, and S. Melmed Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1082 - C1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Ponte, E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, and J. Domenech The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities Stem Cells, July 1, 2007; 25(7): 1737 - 1745. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
